MAM
Monaco Asset Management’s ProQR Therapeutics PRQR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $938K | Sell |
460,000
-11,908
| -3% | -$24.3K | 0.16% | 55 |
|
|
2025
Q1 | $628K | Buy |
471,908
+175,290
| +59% | +$233K | 0.13% | 52 |
|
|
2024
Q4 | $786K | Sell |
296,618
-31,274
| -10% | -$82.9K | 0.11% | 48 |
|
|
2024
Q3 | $597K | Buy |
327,892
+15,263
| +5% | +$27.8K | 0.09% | 51 |
|
|
2024
Q2 | $519K | Hold |
312,629
| – | – | 0.08% | 48 |
|
|
2024
Q1 | $710K | Sell |
312,629
-65,847
| -17% | -$149K | 0.21% | 38 |
|
|
2023
Q4 | $749K | Buy |
378,476
+959
| +0.3% | +$1.9K | 0.22% | 51 |
|
|
2023
Q3 | $491K | Buy |
377,517
+140,000
| +59% | +$182K | 0.15% | 50 |
|
|
2023
Q2 | $385K | Buy |
237,517
+58,183
| +32% | +$94.3K | 0.11% | 49 |
|
|
2023
Q1 | $382K | Buy |
179,334
+14,334
| +9% | +$30.5K | 0.12% | 50 |
|
|
2022
Q4 | $611K | Sell |
165,000
-766,400
| -82% | -$2.84M | 0.18% | 52 |
|
|
2022
Q3 | $693K | Hold |
931,400
| – | – | 0.27% | 48 |
|
|
2022
Q2 | $724K | Buy |
931,400
+840,500
| +925% | +$653K | 0.32% | 44 |
|
|
2022
Q1 | $82K | Buy |
+90,900
| New | +$82K | 0.03% | 41 |
|